Managed Healthcare Executive November 21, 2021
Akhilesh Ayer

As industries across the board move towards a digital-only world, pharma companies must account for the different technologies that are transforming the R&D process.

Pharma companies have long been playing a critical role in our lives, albeit being in the background. However, COVID-19 has pushed the pharma industry firmly to the foreground. Governments and societies are pinning their hopes on the industry to help prevent the next epidemic while they continue to find cures to known health conditions and diseases.

Navigating a Complex & Fast-changing Landscape

In the wake of the pandemic, pharma companies face a growing number of challenges, especially in relation to Research and Development (R&D). Costs have spiraled over the last decade. In 2020, R&D spending in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Cloud, Digital Health, Pharma, Pharma / Biotech, Technology
Brazil’s plan for low-cost CAR-Ts
PacBio’s Repeat Expansion Panel, Owkin-Sanofi AI Take on Immunology, More
STAT+: Borrowing an idea from cancer immunotherapy, scientists make old-mice immune systems youthful again
Moderna gets Blackstone backing for flu vaccine R&D
FDA Approves Winrevair, Merck’s Novel Treatment for Pulmonary Arterial Hypertension

Share This Article